EMBR-08. CORRELATION OF HISTOPATHOLOGY, CHROMOSOMAL MICROARRAY, AND NANOSTRING BASED 22-GENE ASSAY FOR MEDULLOBLASTOMA SUBGROUP ASSIGNMENT ON “HEAD START” 4 CLINICAL TRIAL

“Head Start” 4 (HS 4) is a prospective randomized clinical trial that tailors treatment based on medulloblastoma molecular subgroups and response to induction chemotherapy to compare the efficacy of one versus three (tandem) cycles of myeloablative therapy. Advances in RNA and DNA profiling have ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhall, Girish, Patel, Parth, Blue, Megan, Biegel, Jaclyn, Almiraz-Suarez, Isabel, Hwang, Eugene, Pierson, Christopher, Boue, Daniel, Finlay, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Embryonal Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168270/
http://dx.doi.org/10.1093/neuonc/noab090.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168270/
http://dx.doi.org/10.1093/neuonc/noab090.026

Ejemplares similares